Authors

Direct contracting: Cutting out the middleman

Employers are bypassing insurers and contracting directly with providers. Direct contracting is not new, but soaring healthcare costs and the weight of fiduciary responsibility are whetting employers’ appetites for this option.

Protecting Vulnerable Lives: The Importance of Improving Vaccine Coverage in Patients with Cancer

Our 2026 conversation with Eric C. Hunter, MBA, president and CEO of CareOregon, part 1

During the first part of a wide-ranging interview with MHE, Hunter discussed behavioral health and financial pressures on the Medicaid managed care plna he runs in Oregon.

The future of pharmacy: What the MHE 2026 Pharmacy Survey signals for the year ahead

The 2026 MHE Pharmacy Survey asked questions about most-favored nation drug pricing, PBM reform and HHS Secretary Robert F. Kennedy Jr.'s vaccine policies. Respondents rated direct-to-consumer drug sales by drugmaker as the most important development in the pharmaceutical sector this year.

Pharmacy Benefits for Today’s Employer Challenges

Sponsored by RxBenefits.

The Shift in Star Ratings That Health Plans Can't Ignore

Transitions of Care (TRC), Medication Reconciliation Post-Discharge (MRP), and Plan All-Cause Readmissions (PCR) are among the measures that have a major effect the Star Rating of health plans.

Bridging the Gap between Providers and Payors Ultimately Benefitting Patients

The bispecific era in multiple myeloma — Future directions: Written recap

C. Brooke Adams, Pharm.D., BCOP, of Orlando Health discusses bispecific antibody therapies for multiple myeloma.

Aflibercept 8 mg Shows Promise in Reducing Injection Burden | AAO 2025

New findings reveal aflibercept 8 mg enhances vision and extends injection intervals for nAMD and DME patients, reducing treatment burden significantly.

Cancer and the Microbiome: A Gut Check | ASCO 2025

Gut bacteria produce metabolites that influence drug metabolism and affect immune cell function, potentially enhancing or inhibiting treatment effectiveness.

The women’s health conversation still has a migraine-sized gap

Women are disproportionately affected by migraine, and people with migraine can lose the ability to consistently participate in work, school and daily life.

Smile Omni Executes at Scale to Turn Intelligence Into Impact

Smile Digital Health’s Intelligence Hub operationalizes computable clinical knowledge into measurable outcomes. Learn how payers and providers use unified data, digital HEDIS, and guideline-driven intelligence to close care gaps, reduce friction, and deliver real ROI.

Q&A: Mayo Clinic leaders share strategies for managing high-cost drugs without breaking the bank | Asembia AXS26 Summit

Mayo Clinic experts said managing high-cost drugs requires clear definitions, strong formulary review processes and closer collaboration among health systems, payers and manufacturers to balance access, cost and quality of care.

As Boundaries of Specialty Pharmacy Change, So Must Patient Support Services | Asembia AXS25

Specialty drugs are increasingly entering general medicine. Experts at Asembia’s AXS Summit say the trend will put a premium on leveraging artificial intelligence, technology and cross-functional expertise to create more personalized, efficient patient support services.

AI’s allure drives some users into the shadows

The use of unsanctioned or unapproved artificial intelligence by healthcare workers created a significant liability risk, experts say.

AI in Pharmacy: Transforming Workflows and Patient Care

Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care

For decades, healthcare organizations have invested billions of dollars to improve clinical care. Yet one of the strongest predictors of health outcomes isn't found in hospitals or physicians' offices—it's whether someone has a stable place to live.

Early Trial of Libtayo Combination Demonstrates Activity in Melanoma

Fianlimab plus Libtayo demonstrated persistent and significant clinical activity in patients with advanced melanoma.

What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care

This webinar on "What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care" includes panelists Lindsay Greenleaf, J.D., MBA; Ryann Hill, M.P.H. and Patrick Cooney, discussing possible changes to healthcare policies and programs under the Trump administration, including the future of the Inflation Reduction and Affordable Care Acts, PBM reform and Medicare Advantage.

What exactly is managed care today?

And what has it achieved? The meaning and achievements of managed care change with the times, the context, the goals — and in the eyes of the beholders.

What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care

This webinar on "What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care" includes panelists Lindsay Greenleaf, J.D., MBA; Ryann Hill, M.P.H. and Patrick Cooney, discussing possible changes to healthcare policies and programs under the Trump administration, including the future of the Inflation Reduction and Affordable Care Acts, PBM reform and Medicare Advantage.

How the Move to Digital Pharmacy Addresses Brick and Mortar Closures | Asembia’s AXS25 Summit

Digital pharmacy solutions can help brick and mortar locations become more efficient, according to Sarah Thomas, VP of sales and commercialization at HealthDyne and David Skomo, COO of HealthDyne.

Treatment Options for Heart Failure Expands With Finerenone | ACC 2025

Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, has been studied extensively in patients with mildly reduced or preserved ejection fraction.

Healthcare Is Local: How Proximity Drives Transformation in Dialysis for Underserved Communities

Sponsored by DaVita.

Remote and in-clinic models target early type 1 diabetes screening | ADA 2026

A fully remote genetic screening program and a multicenter quality improvement initiative both advanced early detection of type 1 diabetes.

Future Modalities for Infertility

Lucy van de Wiel, PhD, discusses how emerging technologies such as in vitro gametogenesis and gene editing show promise for addressing complex infertility cases, potentially revolutionizing reproductive medicine by offering new solutions for patients with genetic disorders, same-sex couples, and those with uterine factor infertility.

Modernizing Pharmacy Benefit Administration: Addressing Legacy System Friction for Health Plans

Cloud-based pharmacy benefit administration (PBA) platforms are providing transparency for pharmacies and patients.

The LOE cliff

As a wave of blockbuster biologics face loss of exclusivity, some hope that there may be a “second phase” of biosimilar adoption.

Aflibercept 8 mg Shows Promise in Reducing Injection Burden | AAO 2025

New findings reveal aflibercept 8 mg enhances vision and extends injection intervals for nAMD and DME patients, reducing treatment burden significantly.